Navitas Life Sciences

Navitas Life Sciences is associated with 5 registered companies on The Company Check; the primary company is Ecron Acunova Limited. Each company page carries the filings, financials, charges and directors of that entity.

Navitas Life Sciences has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include H.I.G. Capital.

All

Institutional

Investor	Description	Founded Year	Domain	Location
H.I.G. Capital	Private equity capital is invested in small and mid-sized businesses.		higcapital.com	Miami, United States

Premium access

Investor details for Navitas Life Sciences

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

• Complete investor list
• Round participation
• Investor portfolios
• Co-investor network

Access investors

Verified entity values are shown only after access is granted.

Ecron Acunova Limited is the primary company behind Navitas Life Sciences. The boards of the 5 registered companies of Navitas Life Sciences currently have 14 directors; the longest-serving is Sukuru Vijaya Lakshmi, appointed in 2010. 77 earlier directors have ceased.

101 people are tracked at Navitas Life Sciences (17 in leadership, 4 in board & advisors, 80 in team); the tracked headcount is 152.

81 more people are available in the full profile.

Figures of Ecron Acunova Limited, the primary company behind Navitas Life Sciences, for FY 2025. Revenue was ₹75.29 Cr (+20% year on year). Net profit was ₹16.19 Cr (22% margin). EBITDA was ₹11.04 Cr (15% margin). Revenue has grown at a compounded annual rate of -6% over three years and -8% over five years.

• ₹75.29 CrRevenue · FY 2025 · +20% YoY
• ₹16.19 CrNet profit · 22% margin
• ₹11.04 CrEBITDA · 15% margin
• ₹42.98 CrPaid-up capital
• 152Employees (provident fund records)
• -6%Revenue CAGR, 3 years
• -8%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Ecron Acunova Limited are on its company page.

Navitas Life Sciences has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include DATACEUTICS and KAI Research.

4 dated milestones of Navitas Life Sciences across 35 years, from founding to its latest funding, stage changes and deals.

1. 1986 Founded Navitas Life Sciences is founded.
2. Jan 2019 Acquisition Acquires DATACEUTICS.
3. Jan 2019 Acquisition Acquires KAI Research.
4. Aug 2021 Exit Acquired by H.I.G. Capital.

The website of Navitas Life Sciences (navitaslifesciences.com) receives about 11.8K visits a month and ranks #1,499,777 among all websites worldwide, #1,975 in Biotechnology and Pharmaceuticals.

• Monthly visits
  11.8K

  ▼ 5.8% vs previous month

• Unique visitors
  5.8K

  per month

• Global rank
  #1,499,777

  among all websites

• Category rank
  #1,975

  Health · Biotechnology and Pharmaceuticals

Websites whose visitors overlap most with Navitas Life Sciences. Affinity shows how closely the audiences match.

Website	Domain	Audience affinity	Monthly visits	Global rank	Profile
pharmout.net	pharmout.net	100%		#1,353,637	–
ipi.academy	ipi.academy	100%		#1,399,825	–
diaglobal.org	diaglobal.org	100%		#445,407	–
Meridian Bioscience	meridianbioscience.com	71%	31.9K	#999,696	View details
Pharmabiz	pharmabiz.com	60%		#665,634	View details
••••••••••	••••••.com	••%	•.•M	#•••••	–

3 companies that operate in the same segment as Navitas Life Sciences (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.

Company	Description	Founded	Location	Total funding	Revenue	Employees
Indegene	Suite solutions are provided for payers and healthcare providers.	1998	Princeton, New Jersey, United States	USD 220 M	USD 374.1 M	5,666
Insulet	Wearable insulin infusion systems are developed for diabetes patients.	2000	Boston, Massachusetts, United States	USD 120.4 M	USD 2.71 B	3,900
MannKind Corp	Developer of small-molecule drugs	1991	Los Angeles, California, United States	USD 50 M	USD 348.97 M	407